Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients

American Journal of Clinical Pathology

Volumn 122, Issue 5, 2004, Pages 728-739

  Goldstein, Neal S ^a   Kestin, Larry L ^a   Vicini, Frank A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast; Carcinoma; Criteria; Pathology; Prognosis; Tubular

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

EID: 7244240819     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/9FEP8U8AUGQNGY3V     Document Type: Article

References (42)

1. Carstens PH, Huvos AG, Foote FW Jr, et al. Tubular carcinoma of the breast: a clinicopathologic study of 35 cases. Am J Clin Pathol. 1972;58:231-238.
2. Tobon H, Salazar H. Tubular carcinoma of the breast: clinical, histological, and ultrastructural observations. Arch Pathol Lab Med. 1977;101:310-316.
3. Cooper HS, Patchefsky AS, Krall RA. Tubular carcinoma of the breast. Cancer. 1978;42:2334-2342.
4. Oberman HA, Fidler WJ Jr. Tubular carcinoma of the breast. Am J Surg Pathol. 1979;3:387-395.
5. Rosen PP. Tubular carcinoma of the breast [letter]. Am J Surg Pathol. 1980;4:207.
6. Peters GN, Wolff M, Haagensen CD. Tubular carcinoma of the breast: clinical pathologic correlations based on 100 cases. Ann Surg. 1981;193:138449.
7. Deos PH, Norris HJ. Well-differentiated (tubular) carcinoma of the breast: a clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol. 1982;78:1-7.
8. McDivitt RW, Boyce W, Gersell D. Tubular carcinoma of the breast: clinical and pathological observations concerning 135 cases. Am J Surg Pathol. 1982;6:401-411.
9. Parl FF, Richardson LD. The histologic and biologic spectrum of tubular carcinoma of the breast. Hum Pathol. 1983;14:694-698.
10. Carstens PH, Greenberg RA, Francis D, et al. Tubular carcinoma of the breast: a long term follow-up. Histopathology. 1985;9:271-280.
11. Ellis IO, Galea M, Broughton N, et al. Pathological prognostic factors in breast cancer, II: histological type: relationship with survival in a large study with long-term follow-up. Histopathology. 1992;20:479-489.
12. Weiss MC, Fowble BL, Solin LJ, et al. Outcome of conservative therapy for invasive breast cancer by histologic subtype. Int J Radiat Oncol Biol Phys. 1992;23:941-947.
13. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer, IV: should you be a typer or a grader? a comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 1995;27:219-226.
14. Goldstein NS, Kestin L, Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: a clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 2003;120:500-527.
15. Carstens PH. Tubular carcinoma of the breast: a study of frequency. AmJ Clin Pathol 1978;70:204-210.
16. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. New York, NY: Churchill Livingstone; 1987.
17. van Bogaert LJ. Clinicopathologic hallmarks of mammary tubular carcinoma. Hum Pathol. 1982;13:558-562.
18. Stalsberg H, Hartmann WH. The delimitation of tubular carcinoma of the breast. Hum Pathol. 2000;31:601-607.
19. Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology. 1979;3:407-419.
20. McBoyle MF, Razek HA, Carter JL, et al. Tubular carcinoma of the breast: an institutional review. Am Surg. 1997;63:639-644.
21. Taylor HB, Norris HJ. Well-differentiated carcinoma of the breast. Cancer. 1970;25:687-692.
22. Rosen PP. Invasive duct carcinoma. In: Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:325-364.
23. Rosen PP, Oberman HA. Invasive carcinoma. In: Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology; 1993:157-257. Rosai J, Sobin LH, eds. Atlas of Tumor Pathology; Third Series, Fascicle 7.
24. Rosen PP, Oberman HA. Invasive carcinoma. In: Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology; 1993:157-257. Rosai J, Sobin LH, eds. Atlas of Tumor Pathology; Third Series, Fascicle 7.
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
26. Pinder SE, Murray S, Ellis IO, et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer. 1998;83:1529-1539.
27. Theissig F, Kunze KD, Haroske G, et al. Histological grading of breast cancer: interobserver, reproducibility and prognostic significance. Pathol Res Pract. 1990;186:732-736.
28. Robbins P, Pinder S, de Klerk N, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 1995;26:873-879.
29. Lagios MD, Rose MR, Margolin FR. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol 1980;73:25-30.
30. Rosen PP, Saigo PE, Braun DW, et al. Prognosis in stage 11 (T1N1M0) breast cancer. Ann Surg. 1981;194:576-584.
31. Tabar L, Fagerberg G, Chen HH, et al. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer. 1996;66:413-419.
32. Winchester DJ, Sahin AA, Tucker SL, et al. Tubular carcinoma of the breast: predicting axillary nodal metastases and recurrence. Ann Surg. 1996;223:342-347.
33. Green I, McCormick B, Cranor M, et al. A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 1997;21:653-657.
34. Diab SG, Clark GM, Osborne CK, et al. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17:1442-1448.
35. Kader HA, Jackson J, Mates D, et al. Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse. Breast J. 2001;7:8-13.
36. Kitchen PR, Smith TH, Henderson MA, et al. Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy. Aust N Z J Surg. 2001;71:27-31.
37. Anan K, Mitsuyama S, Tamae K, et al. Tubular carcinoma of the breast: a histologic subtype indicative of breast-conserving therapy. Surg Today. 2000;30:1057-1061.
38. Elson BC, Helvie MA, Frank TS, et al. Tubular carcinoma of the breast: mode of presentation, mammographic appearance, and frequency of nodal metastases. AJR Am J Roentgenol. 1993;161:1173-1176.
39. Papadatos G, Rangan AM, Psarianos T, et al. Probability of axillary node involvement in patients with tubular carcinoma of the breast. Br J Surg. 2001;88:860-864.
40. Wong SL, Chao C, Edwards MJ, et al. Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg. 2002;184:492-498.
41. Maibenco DC, Weiss LK, Pawlish KS, et al. Axillary lymph node metastases associated with small invasive breast carcinomas. Cancer. 1999;85:1530-1536.
42. Dixon JM, Page DL, Anderson TJ, et al. Long-term survivors after breast cancer. Br J Surg. 1985;72:445-448.